Solubilization of poorly soluble compounds using 2-pyrrolidone

被引:38
作者
Jain, Parijat [1 ]
Yalkowsky, Samuel H. [1 ]
机构
[1] Univ Arizona, Dept Pharm Practice & Sci, Coll Pharm, Tucson, AZ 85721 USA
关键词
2-pyrrolidone; solubilization; cosolvency; complexation;
D O I
10.1016/j.ijpharm.2007.03.056
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The solubilization of nine poorly soluble compounds in aqueous solution by 2-pyrrolidone has been studied. Solubility enhancement as high as 500-fold is achieved using 20% 2-pyrrolidone. A comparison shows that 2-pyrrolidone is a better solubilizer than glycerin, propylene glycol, polyethylene glycol 400 or ethanol. The observed solubilization curves are deconvoluted into components representing complexation and cosolvency. A clear linear relationship exists between the cosolvency solubilization power (a) of 2-pyrrolidone and the partition coefficient (log K-ow) of the drug (R-2 = 0.96) extending over three orders of magnitude. The stability constants for the formation of 1: 1 complex (K-1:1) involving 2-pyrrolidone and the drugs have been calculated. A weaker correlation (R-2 = 0.74) is observed between the complexation constants and the partition coefficients of respective drugs. This study indicates that 2-pyrrolidone, like NMP, can act as a complexant at low concentrations and as a cosolvent at high concentrations and that both these properties are affected by the partition coefficient of the solute. Published by Elsevier B.V.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 23 条
[1]
Bittner B, 2002, PHARM IND, V64, P800
[2]
Bittner B, 2002, CURR OPIN DRUG DI DE, V5, P59
[3]
THE SOLUBILITY AND COMPLEXING PROPERTIES OF OXYTETRACYCLINE AND TETRACYCLINE .1. INTERACTION IN AQUEOUS SOLUTION [J].
GANS, EH ;
HIGUCHI, T .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1957, 46 (08) :458-466
[4]
Solubilization of two structurally related anticancer drugs: XK-469 and PPA [J].
He, Y ;
Tabibi, E ;
Yalkowsky, SH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (01) :97-107
[5]
Higuchi T., 1965, Interscience, New York, V4, P117
[6]
DETERMINATION OF AQUEOUS SOLUBILITY AND PKA VALUES OF ESTROGENS [J].
HURWITZ, AR ;
LIU, ST .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (05) :624-627
[7]
Solubilization of NSC-639829 [J].
Jain, N ;
Yang, G ;
Tabibi, SE ;
Yalkowsky, SH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 225 (1-2) :41-47
[8]
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification [J].
Kasim, Nehal A. ;
Whitehouse, Marc ;
Ramachandran, Chandrasekharan ;
Bermejo, Marival ;
Lennernas, Hans ;
Hussain, Ajaz S. ;
Junginger, Hans E. ;
Stavchansky, Salomon A. ;
Midha, Kamal K. ;
Shah, Vinod P. ;
Amidon, Gordon L. .
MOLECULAR PHARMACEUTICS, 2004, 1 (01) :85-96
[9]
WATER-SOLUBLE COMPLEXES OF THE ANTIVIRAL DRUGS, 9-[(1,3-DIHYDROXY-2-PROPOXY)METHYL]GUANINE AND ACYCLOVIR - THE ROLE OF HYDROPHOBICITY IN COMPLEX-FORMATION [J].
KENLEY, RA ;
JACKSON, SE ;
WINTERLE, JS ;
SHUNKO, Y ;
VISOR, GC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (07) :648-653
[10]
FORMATION OF MOLECULAR COMPLEXES BY SOME WATER-SOLUBLE AMIDES .2. EFFECT OF DECREASING WATER SOLUBILITY ON DEGREE OF COMPLEX FORMATION [J].
KOSTENBAUDER, HB ;
HIGUCHI, T .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1956, 45 (12) :810-813